Illicit cigarette consumption in the EU, UK, Norway and Switzerland. 2021 results
By KPMG
This report of key findings (the ‘Report’) has been prepared by KPMG LLP. The Report was commissioned by PMPSA (Philip Morris Products SA), described in this Important Notice and in this Report as the ‘beneficiary’, on the basis set out in a private contract agreed between the beneficiary and KPMG LLP dated 12 January 2022. Information sources, the scope of our work, and scope and source limitations are set out in the footnotes and methodology contained within this Report. The scope of our work, information sources used, and any scope and source limitations were fixed by agreement with the beneficiary. We have satisfied ourselves, where possible, that the information presented in this Report is consistent with the information sources used, but we have not sought to establish the reliability of the information sources by reference to other evidence. We relied upon and assumed without independent verification, the accuracy and completeness of information available from public and third‐ party sources. This Report has not been designed to benefit any specific organisation other than the beneficiary. In preparing this Report we have not taken into account the interests, needs, or circumstances of any specific organisation, other than the beneficiary.
-
This Report is not suitable to be relied on by any party (other than the beneficiary) wishing to acquire rights or assert any claims against KPMG LLP for any purpose or in any context. As such, any person or entity (other than the beneficiary) who reads this Report and chooses to rely on it (or any part of it) will do so at their own risk. To the fullest extent permitted by law, KPMG LLP does not assume any responsibility and will not accept any liability in respect of this Report other than to the beneficiary. In particular, and without limiting the general statement above, although we have prepared this Report in agreement with the beneficiary, this Report has not been prepared for the benefit of any other manufacturer of tobacco products nor for any other person or entity who might have an interest in the matters discussed in this Report, including for example those who work in or monitor the tobacco or public health sectors or those who provide goods or services to those who operate in those sectors.
London: KPMG, 2022. 231p.